Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-22 | New | $62,640,000 | $62,640,000 | Equity Only | 06b | SEC link |
| 2025-02-28 | New | $20,750,000 | $20,750,000 | Equity Only | 06b | SEC link |
| 2025-02-28 | New | $10,000,002 | $10,000,002 | Equity Only | 06b | SEC link |
| 2024-03-08 | New | $12,870,000 | $12,870,000 | Other | 06b | SEC link |
| 2024-02-22 | New | $14,500,000 | $14,500,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Edward J. Benz, Jr. | Director |
| David M. Cornell, Ii | Director |
| Clifford C. Dasco, M.D. | Director, Executive |
| Lee Fleisher, M.D. | Director |
| Steve Gorlin | Director, Executive |
| William Haseltine, Ph D. | Director |
| David Lonard, Ph D | Executive |
| Bert W. O'malley | Director |
| Bert W. O'malley, M.D. | Director |
| Jonathan W. Simons | Director |
| John Thomas, Jr. | Executive |
| Shawn C. Tomasello | Director, Executive |
| Suneet Varma | Director |